Trials / Conditions / Essential Thrombocytosis
Essential Thrombocytosis
4 registered clinical trials studyying Essential Thrombocytosis — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition NCT06218628 | Fox Chase Cancer Center | Phase 1 |
| Completed | A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative NCT02158858 | Constellation Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis NCT00586651 | Cephalon | Phase 2 |
| Completed | Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders NCT00433862 | National Institutes of Health Clinical Center (CC) | — |